Drug Topics

07/21/2025

Previously, Shingrix required healthcare providers to mix a lyophilized (powder) antigen with a liquid adjuvant from two separate vials before administration.

Read More:

The new presentation of Shingrix will allow for easier administration.

07/21/2025

This strategy is vital for improving patient safety, optimizing medication regimens, and enhancing health outcomes, particularly for older adults and those with multiple chronic conditions.

Read More:

Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.

07/21/2025

Patients discharged from the ICU often face severe malnutrition, muscle weakness, and impaired recovery due to prolonged critical illness and altered metabolic states.

Read More:

In the researchers’ exploration of post-ICU nutritional care, they detailed the clinical pharmacist’s role and provided insights into how this role may evolve in the future.

07/21/2025

Don't miss what pharmacists are talking about!

Pharmacist View is an expert-led video series offering practical, pharmacist-focused insights on timely clinical topics. Our latest series featured is on the regulation, logistics, and reimbursement of implementing point-of-care testing in your community pharmacy.

All episodes are out now: https://hubs.li/Q03y1hhd0

07/21/2025

This year’s National Pharmaceutical Association (NPhA) and Student National Pharmaceutical Association (SNPhA) Annual Convention will be taking place August 1 to 4 in Cincinnati, Ohio.

Read More:

This year’s conference is taking place from August 1 to 4 in Cincinnati, Ohio.

07/17/2025

Care home residents, often elderly and with multiple comorbidities, are at a greatly increased risk of severe pneumococcal disease, including pneumonia, meningitis, and bloodstream infections.

Read More:

Older adults are more likely to have chronic diseases, such as lung disease or heart disease, which makes them more susceptible to invasive pneumococcal disease.

07/17/2025

Reduced resilience in underserved populations likely translated to worse health outcomes, including higher rates of severe illness, hospitalization, and mortality from , as well as increased challenges.

Read More:

Researchers examined the factors attributed to self-reported resilience among diverse and community-dwelling adults during the COVID-19 pandemic.

07/17/2025

The research clearly showed that Black and Hispanic children were hospitalized with at significantly higher rates than their white counterparts, underscoring a stark racial and ethnic disparity.

Read More:

Researchers characterized trends in COVID-19 hospitalizations by race and ethnicity among children from March 2020 to September 2023.

07/17/2025

This advancement adds to the growing arsenal of prevention tools, offering more choices that can be tailored to individual preferences and lifestyles, thereby increasing overall uptake.

Read More:

Investigators find that the phase 2 trial supports the further development of MK-8527 as an HIV pre-exposure prophylaxis.

07/16/2025

AI that works with pharmacists, not around them.

In this new video interview, Julia Vu, PharmD, discusses how ClinicalKey AI is transforming pharmacy practice—helping pharmacists make faster, evidence-based decisions through responsible, transparent AI.

https://hubs.li/Q03sNTXH0

07/16/2025

New data shows that CGRP (calcitonin gene-related peptide) medications, highly effective for migraines, did not prove effective in preventing cluster headache attacks.

Read More:

Investigators find that erenumab, a calcitonin gene-related peptide receptor (CGRP) monoclonal antibody, is not a preventative treatment for chronic cluster headache.

07/16/2025

Researchers addressed the current trends in prescription drug use and spending among Medicare Advantage beneficiaries during the first year of clinician access to a real-time prescription benefit tool.

Read More:

Researchers addressed the current trends in prescription drug use and spending among Medicare Advantage beneficiaries during the first year of clinician access to a real-time prescription benefit tool.